Cargando…
THU345 SGLT2 Inhibitors Reduce Mortality In Patients With Acute Myocardial Infarction And Percutaneous Coronary Intervention: A Systematic Review And Meta-analysis
Disclosure: S.G. Ribeiro: None. P.E. Carvalho: None. A.B. Neto: None. N. Felix: None. L. Teixeira: None. M.M. Gauza: None. M.S. Guisso: None. C.C. Jorge: None. P.M. Camara: None. J.C. Neto: None. A.R. Amaral: None. J.D. Sa: None. Background: The effects of sodium-glucose cotransporter 2 inhibitors (...
Autores principales: | Goncalves Ribeiro, Sandro Augusto, Carvalho, Pedro E P, do Amaral Neto, Augusto Barreto, Felix, Nicole, Teixeira, Larissa, Gauza, Mateus Miranda, Schramm Guisso, Maria Eduarda, Campelo Jorge, Carlos Alberto, da Camara, Pedro Matos, Costa Neto, Jose Amir, do Amaral, Adilaine Rosa, de Sa, Joao Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554995/ http://dx.doi.org/10.1210/jendso/bvad114.778 |
Ejemplares similares
-
THU387 Euglycemic Diabetic Ketoacidosis And SGLT-2 Inhibitor Use
por: Abrahimi, Nora, et al.
Publicado: (2023) -
THU360 Hyperglycemic DKA In Patient On Monotherapy With SGLT-2 Inhibitor
por: Ahmed, Samihah, et al.
Publicado: (2023) -
THU389 Euglycemic Diabetic Ketoacidosis With Prolonged Ketosis Due To SGLT-2 Inhibitor
por: Viera Feliciano, Natalia, et al.
Publicado: (2023) -
THU247 Characterizing Inpatient Cases Of DKA Precipitated By SGLT2 Inhibitor Use
por: Aslamy, Arianne, et al.
Publicado: (2023) -
THU282 Improved Fournier’s Gangrene Outcomes With Prior SGLT2i Or Metformin Usage
por: Venugopal, Sharini, et al.
Publicado: (2023)